Carolyn A. Brown, MSPH, PhD

ViiV Healthcare
Atlanta, Georgia, United States

Disclosure(s): ViiV Healthcare/GSK: Stocks/Bonds (Public Company)

Presentation(s):

• 505 - Real-World Use of Cabotegravir Long-Acting for Pre-Exposure Prophylaxis: Data from Trio Health Cohort

  Saturday, October 19, 2024
  10:45 AM – 11:00 AM US PT

• 508 - Cabotegravir Long-Acting for Pre-Exposure Prophylaxis (PrEP): Real World Data on On-Time Dosing, HIV Testing and HIV Acquisition from the OPERA Cohort

  Saturday, October 19, 2024
  11:30 AM – 11:45 AM US PT